What is Altris AI?
The system facilitates early detection of over 70 retina pathologies and biomarkers, including early glaucoma risk assessment and quantitative analysis for monitoring disease progression. Altris AI enhances patient care by enabling more detailed screenings, leading to earlier detection and more effective treatment strategies. It also serves as an educational tool for patients, helping them understand their condition and treatment plan, thereby increasing compliance and loyalty. The platform adheres to strict compliance standards, including FDA clearance, CE certification, GDPR, and HIPAA.
Features
- Automated Pathological OCT Scan Selection: Identifies relevant scans needing further review.
- Detection of 70+ Pathologies and Biomarkers: Comprehensive analysis of retinal conditions.
- Early Glaucoma Risk Assessment: Utilizes AI for early glaucoma detection analysis.
- Quantitative Biomarkers Analysis: Tracks changes in pathologies over time.
- AI-powered Optic Disc Analysis: Assesses optic disc health for conditions like glaucoma.
- GCC Asymmetry Analysis: Complements glaucoma assessment.
- Compatibility with all OCT devices: Integrates with existing hardware.
- Patient Education Tool: Color-coded images help explain conditions to patients.
Use Cases
- Assisting ophthalmologists with OCT scan interpretation.
- Helping optometrists enhance diagnostic capabilities using OCT scans.
- Improving patient triage in eye care clinics.
- Enabling early detection of retinal diseases like diabetic retinopathy, AMD, and glaucoma.
- Monitoring the progression of eye pathologies over time.
- Educating patients about their eye conditions using visualized AI analysis.
- Reducing diagnostic errors and burnout for eye care professionals.
- Supporting clinical research with AI-driven OCT analysis.
Helpful for people in the following professions
Featured Tools
Join Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.